Solana Beach, CA, United States of America

Garth J Cooper


Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 165(Granted Patents)


Company Filing History:


Years Active: 1992-2000

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Garth J Cooper: Innovator in Diabetes Research

Introduction

Garth J Cooper is a prominent inventor based in Solana Beach, California. He has made significant contributions to the field of diabetes research, holding a total of 7 patents. His work focuses on amylin, a peptide associated with diabetes, and he has developed novel methods for evaluating compounds that can simulate its effects.

Latest Patents

Among his latest patents, Garth has developed methods for amylin activity assays. These methods are designed to identify or assay compounds that can simulate the ability of amylin to cause hyperlactemia and hyperglycemia in in vivo biological models. The process involves introducing test samples into in vivo test systems and determining the presence or amount of a rise in lactate and glucose following test sample administration. Additionally, he has patented biologically active peptides associated with diabetes, specifically amylin. This invention includes peptides with a specific amino acid sequence and methods for preparing and assaying them, which can be derived from diabetic pancreata or synthesized using recombinant DNA techniques.

Career Highlights

Garth J Cooper has been instrumental in advancing diabetes research through his innovative approaches and patented technologies. His work at Amylin Pharmaceuticals, Inc. has positioned him as a key figure in the development of treatments for Type 2 diabetes. His contributions have not only enhanced scientific understanding but also paved the way for potential therapeutic applications.

Collaborations

Garth has collaborated with notable colleagues, including Andrew A Young and Brendan Leighton. These partnerships have further enriched his research and development efforts in the field of diabetes.

Conclusion

Garth J Cooper's innovative work in diabetes research, particularly in relation to amylin, has led to significant advancements in understanding and potentially treating this condition. His contributions through patents and collaborations highlight his role as a leading inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…